Option Care Health 3Q 2026: Revenue $1.49B, EPS $0.38— 10-Q Summary
Option Care Health reported Q3 2026 revenue of $1.49B, up 4.1% YoY, and net income of $57.4M, up 10.8% YoY. EPS rose to $0.38 from $0.32. Nine-month revenue increased 2.5% YoY to $4.29B. Management expects CID-related dynamics to reduce 2026 gross profit by $55M.
How this was made
The 30-second read
Why it matters
The earnings release adds new quantitative data that could influence short‑term trading decisions, though the magnitude is limited.
Market read
First disclosure of Q3 2026 results; modest growth may lead to limited price movement.
What to watch
Inventory improvements and supply‑chain initiatives may improve margins despite flat revenue growth.
Background
Option Care Health is a provider of home infusion and specialty pharmacy services. The 10‑Q filing presents its third‑quarter financials for 2026.
Ticker impact
Option Care Health reported Q3 2026 revenue of $1.49B and EPS of $0.38, the first public disclosure of these results.
likely slight pressure as the market digests modest growth versus expectations
The report shows modest YoY revenue growth (4.1%) and EPS increase (0.38 vs 0.32). Without clear beat or miss, traders may react cautiously.
Market effects
Provides a data point for the home health and infusion services sector, indicating modest growth.
Limited to U.S. small‑cap healthcare investors.
Low global impact; primarily relevant to niche investors.
Counterpoint
If expectations were for stronger growth, the modest results could trigger a sell‑off.
Key entities
- companyOption Care Health, Inc.
U.S. home health and infusion services provider.
